We take part in ConcePTION – safety evidence ecosystem

On April a landmark public private partnership called ConcePTION was awarded a 5-year grant by the Innovative Medicines Initiative (IMI2) to tackle many of the research gaps related to medicine used by pregnant and breastfeeding women.

The project unites an unprecedented 88 organizations from 22 countries, including our team PERUN AAI, which provides access to sensitive data, the European Medicines Agency, drug manufacturers, academia, public health organizations, and teratology networks to innovate new solutions to decades-long public health issues. 

With a shared vision that there is a societal obligation to radically and rapidly reduce uncertainty about the safety of medication use in pregnancy and breastfeeding, the ConcePTION team will work to create sustainable solutions to the problem. Through better use of existing health data from routine, daily practice together with enhanced methods to collect patient-reported data, and with new research capabilities to predict and measure maternal medication in breastmilk, the team hopes to close the information gap.

The complete press release of project ConcepTION is available here.